We use essential cookies and third-party cookies for content.

Choose a language

Automatically close in : 3

Wie gewohnt mit Werbung lesen

Nutzen Sie San Francisco Frontiers mit personalisierter Werbung, Werbetracking, Nutzungsanalyse und externen Multimedia-Inhalten. Details zu Cookies und Verarbeitungszwecken sowie zu Ihrer jederzeitigen Widerrufsmöglichkeit finden Sie unten, im Cookie-Manager sowie in unserer Datenschutzerklärung.

Deutsch

Read as usual with advertising

Use San Francisco Frontiers with personalised advertising, ad tracking, usage analysis and external multimedia content. Details on cookies and processing purposes as well as your revocation option at any time can be found below, in the cookie manager as well as in our privacy policy.

English

Lea como siempre con publicidad

Utilizar San Francisco Frontiers con publicidad personalizada, seguimiento de anuncios, análisis de uso y contenido multimedia externo. Los detalles sobre las cookies y los propósitos de procesamiento, así como su opción de revocación en cualquier momento, se pueden encontrar a continuación, en el gestor de cookies, así como en nuestra política de privacidad.

Español

Lire comme d'habitude avec de la publicité

Utilisez le San Francisco Frontiers avec des publicités personnalisées, un suivi publicitaire, une analyse de l'utilisation et des contenus multimédias externes. Vous trouverez des détails sur les cookies et les objectifs de traitement ainsi que sur votre possibilité de révocation à tout moment ci-dessous, dans le gestionnaire de cookies ainsi que dans notre déclaration de protection des données.

Français

Leggere come sempre con la pubblicità

Utilizzare San Francisco Frontiers con pubblicità personalizzata, tracciamento degli annunci, analisi dell'utilizzo e contenuti multimediali esterni. I dettagli sui cookie e sulle finalità di elaborazione, nonché la possibilità di revocarli in qualsiasi momento, sono riportati di seguito nel Cookie Manager e nella nostra Informativa sulla privacy.

Italiano

Ler como de costume com publicidade

Utilizar o San Francisco Frontiers com publicidade personalizada, rastreio de anúncios, análise de utilização e conteúdo multimédia externo. Detalhes sobre cookies e fins de processamento, bem como a sua opção de revogação em qualquer altura, podem ser encontrados abaixo, no Gestor de Cookies, bem como na nossa Política de Privacidade.

Português

San Francisco Frontiers - AstraZeneca buys US biotech firm CinCor

Politics
Economy
Sports
Boulevard
Automotive
Technology
Health
Nature
Culture
Education
Things to know
Weather

London 27 °C
Manchester 25 °C
Glasgow 18 °C
Dublin 21 °C
Belfast 20 °C
Washington 30 °C
Denver 27 °C
Atlanta 28 °C
Dallas 37 °C
Houston Texas 33 °C
New Orleans 29 °C
El Paso 29 °C
Phoenix 31 °C
Los Angeles 23 °C
San Diego 23 °C
San Francisco 18 °C
Chicago 20 °C
Minneapolis 19 °C
Seattle 24 °C
Portland 26 °C
Salt Lake City 26 °C
Las Vegas 34 °C
Miami 33 °C
Jacksonville 32 °C
San Antonio 34 °C
Bermuda 31 °C
Nassau 28 °C
Iqaluit 8 °C
Yellowknife 22 °C
Anchorage 10 °C
Fairbanks 10 °C
Barrow 2 °C
Calgary 22 °C
Edmonton 28 °C
Winnipeg 19 °C
Goose Bay 19 °C
Halifax 26 °C
Boston 27 °C
Ottawa 16 °C
Toronto 18 °C
Detroit 20 °C
Cleveland 18 °C
New York 29 °C
Baltimore 30 °C
Philadelphia 29 °C
Nuuk (Godthåb) 5 °C
Hong Kong 28 °C
Singapore 27 °C
Melbourne 32 °C
Canberra 7 °C
Adelaide 11 °C
Darwin 19 °C
Perth 10 °C
Fort Worth 36 °C
Honolulu 24 °C
Sydney 10 °C
Johannesburg 17 °C
Dubai 32 °C
Mumbai 27 °C
Zürich 28 °C
Tokyo 30 °C
Seoul 25 °C
Delhi 33 °C
Beijing 23 °C
Riyadh 42 °C
Prague 22 °C
Pennsylvania 27 °C
Valletta 30 °C
Manama 34 °C
Warsaw 23 °C
Stockholm 14 °C

--

UK fintech Revolut valuation soars to $115 bn: source
Philipsen ends 'horrible' drought with Tour de France 17th stage victory
German FM, on Africa tour, eyes business ties amid US, China pressure
Hungary's Orban says graft case is 'pretext' to target his party
Rubio says at ASEAN meeting he expects 'positive' US visit by China's Xi
South African tycoon Motsepe rules out presidential bid
Philipsen wins Tour de France 17th stage
Trump threatens Iran bridges, power as payback for Hormuz attacks
DonnaPro Introduces AI-Trained Executive Assistants for European CEOs
Germany's Merz replaces leader ousted over surrogacy row

×

NYSE - LSE

RBGPF	0%	67.35	$
CMSD	-0.14%	22.17	$
CMSC	-0.25%	21.94	$
NGG	2.06%	83.78	$
RIO	1.91%	92.31	$
BCE	-0.02%	21.645	$
RELX	0.5%	32.895	$
GSK	0.27%	50.92	$
RYCEF	2.03%	18.75	$
BP	1.3%	43.325	$
AZN	0.2%	169.685	$
VOD	1.61%	15.52	$
BTI	1.17%	62.15	$
BCC	2.12%	76.01	$
JRI	0.08%	12.94	$

AstraZeneca buys US biotech firm CinCor

ECONOMY 09.01.2023

San Francisco Frontiers

Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.

Text size:

The takeover marks the latest push by Astra chief executive Pascal Soriot to bolster the Covid vaccine maker's pipeline of new products.

Massachusetts-based CinCor focuses on developing treatments for hypertension and chronic kidney disease.

Since taking the helm at AstraZeneca in 2012, Frenchman Soriot has expanded the company into lucrative cancer therapies.

The group completed a blockbuster takeover of Alexion for $39 billion in 2021, giving it more heft in areas such as treating blood disorders.

F.Edwards--SFF

Featured

Samsung launches new, more expensive foldable smartphones

IMPRINT
TERMS OF USE
PRIVACY POLICY
ADVERTISEMENT